脳血管塞栓術の2030年までの市場予測：製品別、施術別、エンドユーザー別、地域別の世界分析

Stratistics MRCによると、脳血管塞栓術の世界市場は2023年に15億2,000万米ドルを占め、予測期間中にCAGR 8.4％で成長し、2030年には26億7,000万米ドルに達すると予測されています。

脳血管塞栓術は、脳や神経系の血管に影響を及ぼす様々な症状の治療に用いられる医療処置です。これは、粒子、コイル、液体物質などの塞栓剤を血管内に意図的に導入し、異常な血管構造を治療するために使用される標的領域への血流を遮断または減少させることを含みます。さらに、罹患した血管の血流を遮断または減少させることにより、脳血管塞栓術は症状を緩和し、さらなる損傷を防ぎ、血管全体の安定を促進するのに役立ちます。

脳動脈瘤財団によると、米国ではおよそ670万人が未破裂の脳動脈瘤を有しており、年間10万人当たり8～10例の破裂率を示しています。

ヘルスケア・インフラの拡大

ヘルスケア・インフラの拡充は、医療機関、業界利害関係者、規制当局間の協力体制を促進し、研究開発イニシアチブを促進します。このような拡大は、神経血管障害の負担増に対処するだけでなく、タイムリーな診断と介入を可能にします。さらに、協力的な環境は、塞栓材料、送達システム、手技の継続的な改善をサポートし、脳血管塞栓術の分野全体の進歩に貢献しています。

限られた認識と教育

認知度が低いため、脳血管塞栓術が十分に利用されず、患者は代替療法を選択せざるを得ないです。この手技に関する一般向けの教育キャンペーンや情報普及の欠如は、診断や治療の遅れにつながります。さらに、脳血管塞栓術は複雑であり、その実施には専門的な技術が必要であるため、普及の障壁となり、市場拡大の妨げとなっています。

技術の進歩

塞栓物質、送達システム、イメージング技術における技術の進歩や革新は、脳血管塞栓術の精度、安全性、有効性を著しく向上させています。マイクロカテーテルやナビゲーションツールを含む高度な送達システムにより、神経インターベンショニストは複雑な血管構造に到達することができます。さらに、人工知能（AI）と機械学習の統合は、手技の計画と実行をさらに洗練させ、結果を最適化し、手技時間を短縮します。

経済不況

景気後退は脳血管塞栓術を受ける患者の経済力に影響を与え、しばしば制約やコスト削減策に直面します。このため、医療処置のための資金が減少し、個人が適切な医療保険適用を確保する上で課題に直面したり、リソースが限られたりする可能性があります。さらに、景気後退は、医師の診療や紹介パターンを含むヘルスケアのエコシステム全体を混乱させる可能性があります。医師は患者数の減少や異動に見舞われる可能性があり、これがこの市場を阻害しています。

COVID-19の影響

COVID-19の大流行は脳血管塞栓術市場にいくつかの悪影響を与えました。パンデミックは世界のヘルスケアサービスの混乱につながり、塞栓術のような特定の神経血管インターベンションを含む手技は延期または中止され、手技量全体に影響を与えました。物流の課題も、脳血管塞栓術に使用されるものを含む医療機器の入手性に影響を与えました。さらに、ヘルスケアの優先順位の変化や医療制度に対する財政的負担も、この市場規模の妨げとなっています。

予測期間中、塞栓コイル分野が最大になる見込み

塞栓コイル分野は、脳の血管異常の治療に重点が置かれているため、最大のシェアを占めると推定されます。この手法では、カテーテルを介してプラチナやその他の生体適合性コイルを血管に直接留置します。これらのコイルは血栓形成を誘導し、自然治癒プロセスを促進し、破裂のリスクを防ぐ。さらに、動脈瘤や動静脈奇形を含む脳血管疾患の治療に汎用性があり、現在進行中の研究開発努力も相まって、このセグメントの拡大を後押ししています。

予測期間中、動脈瘤コイリング・塞栓術のCAGRが最も高くなると予測される分野

動脈瘤のコイリングおよび塞栓術セグメントは、予測期間中に最も高いCAGRが見込まれます。動脈瘤コイリング・塞栓術は、脳の血管異常を治療するための重要な治療法であり、カテーテルを血管を通して動脈瘤の部位まで誘導します。その後、プラチナコイルまたは他の塞栓デバイスが動脈瘤に展開され、血栓形成を促進し、破裂を防ぐ。さらに、動脈瘤のコイリングおよび塞栓術は、侵襲性が低く、回復に要する時間が短く、合併症のリスクも低いため、医療従事者と患者の双方における認知度が高まっており、この市場の持続的な成長に寄与しています。

最大のシェアを占める地域

アジア太平洋地域は、需要の増加とヘルスケアインフラの進歩により、予測期間中最大の市場シェアを占めました。ヘルスケアに対する意識の高まり、診断能力の向上、ヘルスケアサービスへのアクセスの拡大が、脳血管塞栓術の需要を高めています。さらに、医療機関と業界関係者の協力により、革新的な塞栓材料や器具が開発・導入され、この地域の成長を牽引しています。

CAGRが最も高い地域：

欧州は、塞栓術を含む先進的な神経インターベンション治療に対する認識が高まっていることから、予測期間中に最も高いCAGRを示すと予想されています。Medtronic plc、Penumbra, Inc、MicroVention、Acandis GmbHなどの主要企業は、ヘルスケアシステムにおける技術的進歩を進化させ続け、患者の転帰改善に貢献しています。さらに、動脈瘤や動静脈などの脳血管疾患の増加が、この地域の拡大を後押ししています。

無料カスタマイズサービス：

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

• 企業プロファイル
  • 追加市場プレイヤーの包括的プロファイリング（3社まで）
  • 主要企業のSWOT分析（3社まで）
• 地域セグメンテーション
  • 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
• 競合ベンチマーキング
  • 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

目次

第1章 エグゼクティブサマリー

第2章 序文

• 概要
• ステークホルダー
• 調査範囲
• 調査手法
  • データマイニング
  • データ分析
  • データ検証
  • 調査アプローチ
• 調査ソース
  • 1次調査ソース
  • 2次調査ソース
  • 前提条件

第3章 市場動向分析

• 促進要因
• 抑制要因
• 機会
• 脅威
• 製品分析
• エンドユーザー分析
• 新興市場
• 新型コロナウイルス感染症（COVID-19）の影響

第4章 ポーターのファイブフォース分析

• 供給企業の交渉力
• 買い手の交渉力
• 代替品の脅威
• 新規参入業者の脅威
• 競争企業間の敵対関係

第5章 世界の脳血管塞栓術市場：製品別

• 分流装置
• 動脈瘤クリップ
• 塞栓コイル
• 液体塞栓剤/システム
• その他の製品

第6章 世界の脳血管塞栓術市場：施術別

• 動静脈奇形（AVM）塞栓術
• 動脈瘤のコイル化と塞栓術
• その他の施術

第7章 世界の脳血管塞栓術市場：エンドユーザー別

• 専門クリニック
• 病院
• その他のエンドユーザー

第8章 世界の脳血管塞栓術市場：地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン
  • その他欧州
• アジア太平洋地域
  • 日本
  • 中国
  • インド
  • オーストラリア
  • ニュージーランド
  • 韓国
  • その他アジア太平洋地域
• 南米
  • アルゼンチン
  • ブラジル
  • チリ
  • その他南米
• 中東とアフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • カタール
  • 南アフリカ
  • その他中東とアフリカ

第9章 主な発展

• 契約、パートナーシップ、コラボレーション、合弁事業
• 買収と合併
• 新製品の発売
• 事業拡大
• その他の主要戦略

第10章 企業プロファイル

• Cerenovus
• Penumbra Inc
• Medtronic
• Phenox GmbH
• Stryker
• Balt SAS
• Shape Memory Medical Inc
• Integra LifeSciences
• B. Braun Melsungen AG
• MicroVention Inc
• Peter Lazic GmbH
• Spartan Micro

List of Tables

• Table 1 Global Neurovascular Embolization Market Outlook, By Region (2021-2030) ($MN)
• Table 2 Global Neurovascular Embolization Market Outlook, By Product (2021-2030) ($MN)
• Table 3 Global Neurovascular Embolization Market Outlook, By Flow Diversion Devices (2021-2030) ($MN)
• Table 4 Global Neurovascular Embolization Market Outlook, By Aneurysm Clips (2021-2030) ($MN)
• Table 5 Global Neurovascular Embolization Market Outlook, By Embolic Coils (2021-2030) ($MN)
• Table 6 Global Neurovascular Embolization Market Outlook, By Liquid Embolic Agents/Systems (2021-2030) ($MN)
• Table 7 Global Neurovascular Embolization Market Outlook, By Other Products (2021-2030) ($MN)
• Table 8 Global Neurovascular Embolization Market Outlook, By Procedure (2021-2030) ($MN)
• Table 9 Global Neurovascular Embolization Market Outlook, By Arteriovenous Malformation (AVM) Embolization (2021-2030) ($MN)
• Table 10 Global Neurovascular Embolization Market Outlook, By Aneurysm Coiling and Embolization (2021-2030) ($MN)
• Table 11 Global Neurovascular Embolization Market Outlook, By Other Procedures (2021-2030) ($MN)
• Table 12 Global Neurovascular Embolization Market Outlook, By End User (2021-2030) ($MN)
• Table 13 Global Neurovascular Embolization Market Outlook, By Specialty Clinics (2021-2030) ($MN)
• Table 14 Global Neurovascular Embolization Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 15 Global Neurovascular Embolization Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 16 North America Neurovascular Embolization Market Outlook, By Country (2021-2030) ($MN)
• Table 17 North America Neurovascular Embolization Market Outlook, By Product (2021-2030) ($MN)
• Table 18 North America Neurovascular Embolization Market Outlook, By Flow Diversion Devices (2021-2030) ($MN)
• Table 19 North America Neurovascular Embolization Market Outlook, By Aneurysm Clips (2021-2030) ($MN)
• Table 20 North America Neurovascular Embolization Market Outlook, By Embolic Coils (2021-2030) ($MN)
• Table 21 North America Neurovascular Embolization Market Outlook, By Liquid Embolic Agents/Systems (2021-2030) ($MN)
• Table 22 North America Neurovascular Embolization Market Outlook, By Other Products (2021-2030) ($MN)
• Table 23 North America Neurovascular Embolization Market Outlook, By Procedure (2021-2030) ($MN)
• Table 24 North America Neurovascular Embolization Market Outlook, By Arteriovenous Malformation (AVM) Embolization (2021-2030) ($MN)
• Table 25 North America Neurovascular Embolization Market Outlook, By Aneurysm Coiling and Embolization (2021-2030) ($MN)
• Table 26 North America Neurovascular Embolization Market Outlook, By Other Procedures (2021-2030) ($MN)
• Table 27 North America Neurovascular Embolization Market Outlook, By End User (2021-2030) ($MN)
• Table 28 North America Neurovascular Embolization Market Outlook, By Specialty Clinics (2021-2030) ($MN)
• Table 29 North America Neurovascular Embolization Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 30 North America Neurovascular Embolization Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 31 Europe Neurovascular Embolization Market Outlook, By Country (2021-2030) ($MN)
• Table 32 Europe Neurovascular Embolization Market Outlook, By Product (2021-2030) ($MN)
• Table 33 Europe Neurovascular Embolization Market Outlook, By Flow Diversion Devices (2021-2030) ($MN)
• Table 34 Europe Neurovascular Embolization Market Outlook, By Aneurysm Clips (2021-2030) ($MN)
• Table 35 Europe Neurovascular Embolization Market Outlook, By Embolic Coils (2021-2030) ($MN)
• Table 36 Europe Neurovascular Embolization Market Outlook, By Liquid Embolic Agents/Systems (2021-2030) ($MN)
• Table 37 Europe Neurovascular Embolization Market Outlook, By Other Products (2021-2030) ($MN)
• Table 38 Europe Neurovascular Embolization Market Outlook, By Procedure (2021-2030) ($MN)
• Table 39 Europe Neurovascular Embolization Market Outlook, By Arteriovenous Malformation (AVM) Embolization (2021-2030) ($MN)
• Table 40 Europe Neurovascular Embolization Market Outlook, By Aneurysm Coiling and Embolization (2021-2030) ($MN)
• Table 41 Europe Neurovascular Embolization Market Outlook, By Other Procedures (2021-2030) ($MN)
• Table 42 Europe Neurovascular Embolization Market Outlook, By End User (2021-2030) ($MN)
• Table 43 Europe Neurovascular Embolization Market Outlook, By Specialty Clinics (2021-2030) ($MN)
• Table 44 Europe Neurovascular Embolization Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 45 Europe Neurovascular Embolization Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 46 Asia Pacific Neurovascular Embolization Market Outlook, By Country (2021-2030) ($MN)
• Table 47 Asia Pacific Neurovascular Embolization Market Outlook, By Product (2021-2030) ($MN)
• Table 48 Asia Pacific Neurovascular Embolization Market Outlook, By Flow Diversion Devices (2021-2030) ($MN)
• Table 49 Asia Pacific Neurovascular Embolization Market Outlook, By Aneurysm Clips (2021-2030) ($MN)
• Table 50 Asia Pacific Neurovascular Embolization Market Outlook, By Embolic Coils (2021-2030) ($MN)
• Table 51 Asia Pacific Neurovascular Embolization Market Outlook, By Liquid Embolic Agents/Systems (2021-2030) ($MN)
• Table 52 Asia Pacific Neurovascular Embolization Market Outlook, By Other Products (2021-2030) ($MN)
• Table 53 Asia Pacific Neurovascular Embolization Market Outlook, By Procedure (2021-2030) ($MN)
• Table 54 Asia Pacific Neurovascular Embolization Market Outlook, By Arteriovenous Malformation (AVM) Embolization (2021-2030) ($MN)
• Table 55 Asia Pacific Neurovascular Embolization Market Outlook, By Aneurysm Coiling and Embolization (2021-2030) ($MN)
• Table 56 Asia Pacific Neurovascular Embolization Market Outlook, By Other Procedures (2021-2030) ($MN)
• Table 57 Asia Pacific Neurovascular Embolization Market Outlook, By End User (2021-2030) ($MN)
• Table 58 Asia Pacific Neurovascular Embolization Market Outlook, By Specialty Clinics (2021-2030) ($MN)
• Table 59 Asia Pacific Neurovascular Embolization Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 60 Asia Pacific Neurovascular Embolization Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 61 South America Neurovascular Embolization Market Outlook, By Country (2021-2030) ($MN)
• Table 62 South America Neurovascular Embolization Market Outlook, By Product (2021-2030) ($MN)
• Table 63 South America Neurovascular Embolization Market Outlook, By Flow Diversion Devices (2021-2030) ($MN)
• Table 64 South America Neurovascular Embolization Market Outlook, By Aneurysm Clips (2021-2030) ($MN)
• Table 65 South America Neurovascular Embolization Market Outlook, By Embolic Coils (2021-2030) ($MN)
• Table 66 South America Neurovascular Embolization Market Outlook, By Liquid Embolic Agents/Systems (2021-2030) ($MN)
• Table 67 South America Neurovascular Embolization Market Outlook, By Other Products (2021-2030) ($MN)
• Table 68 South America Neurovascular Embolization Market Outlook, By Procedure (2021-2030) ($MN)
• Table 69 South America Neurovascular Embolization Market Outlook, By Arteriovenous Malformation (AVM) Embolization (2021-2030) ($MN)
• Table 70 South America Neurovascular Embolization Market Outlook, By Aneurysm Coiling and Embolization (2021-2030) ($MN)
• Table 71 South America Neurovascular Embolization Market Outlook, By Other Procedures (2021-2030) ($MN)
• Table 72 South America Neurovascular Embolization Market Outlook, By End User (2021-2030) ($MN)
• Table 73 South America Neurovascular Embolization Market Outlook, By Specialty Clinics (2021-2030) ($MN)
• Table 74 South America Neurovascular Embolization Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 75 South America Neurovascular Embolization Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 76 Middle East & Africa Neurovascular Embolization Market Outlook, By Country (2021-2030) ($MN)
• Table 77 Middle East & Africa Neurovascular Embolization Market Outlook, By Product (2021-2030) ($MN)
• Table 78 Middle East & Africa Neurovascular Embolization Market Outlook, By Flow Diversion Devices (2021-2030) ($MN)
• Table 79 Middle East & Africa Neurovascular Embolization Market Outlook, By Aneurysm Clips (2021-2030) ($MN)
• Table 80 Middle East & Africa Neurovascular Embolization Market Outlook, By Embolic Coils (2021-2030) ($MN)
• Table 81 Middle East & Africa Neurovascular Embolization Market Outlook, By Liquid Embolic Agents/Systems (2021-2030) ($MN)
• Table 82 Middle East & Africa Neurovascular Embolization Market Outlook, By Other Products (2021-2030) ($MN)
• Table 83 Middle East & Africa Neurovascular Embolization Market Outlook, By Procedure (2021-2030) ($MN)
• Table 84 Middle East & Africa Neurovascular Embolization Market Outlook, By Arteriovenous Malformation (AVM) Embolization (2021-2030) ($MN)
• Table 85 Middle East & Africa Neurovascular Embolization Market Outlook, By Aneurysm Coiling and Embolization (2021-2030) ($MN)
• Table 86 Middle East & Africa Neurovascular Embolization Market Outlook, By Other Procedures (2021-2030) ($MN)
• Table 87 Middle East & Africa Neurovascular Embolization Market Outlook, By End User (2021-2030) ($MN)
• Table 88 Middle East & Africa Neurovascular Embolization Market Outlook, By Specialty Clinics (2021-2030) ($MN)
• Table 89 Middle East & Africa Neurovascular Embolization Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 90 Middle East & Africa Neurovascular Embolization Market Outlook, By Other End Users (2021-2030) ($MN)

According to Stratistics MRC, the Global Neurovascular Embolization Market is accounted for $1.52 billion in 2023 and is expected to reach $2.67 billion by 2030 growing at a CAGR of 8.4% during the forecast period. Neurovascular embolization is a medical procedure used to treat various conditions affecting the blood vessels of the brain and nervous system. It involves the intentional introduction of embolic agents, such as particles, coils, or liquid substances, into the blood vessels to block or reduce blood flow to targeted areas employed to treat abnormal vascular structures. Furthermore, by occluding or reducing blood flow to the affected vessels, neurovascular embolization helps to alleviate symptoms, prevent further damage, and promote overall vascular stability.

According to the Brain Aneurysms Foundation, in the U.S., roughly 6.7 million people have unruptured brain aneurysms, leading to an annual rupture rate of 8-10 cases per 100,000.

Market Dynamics:

Driver:

Expansion of Healthcare Infrastructure

The expansion of healthcare infrastructure facilitates collaborative efforts between healthcare institutions, industry stakeholders, and regulatory bodies, fostering research and development initiatives. This expansion not only addresses the growing burden of neurovascular disorders but also enables timely diagnosis and intervention. Moreover, a collaborative environment supports the continuous improvement of embolic materials, delivery systems, and procedural techniques, contributing to the overall advancement of the neurovascular embolization field.

Restraint:

Limited awareness and education

The limited awareness can lead to underutilization of neurovascular embolization, with patients being directed towards alternative treatments. Lack of public education campaigns and information dissemination about the procedure can result in delayed diagnosis and treatment. Furthermore, the complexity of neurovascular embolization and the specialized skills required to perform the procedure can be a barrier to its widespread adoption, which is impeding this market expansion.

Opportunity:

Technological advancements

The advancements in technology and innovations in embolic materials, delivery systems, and imaging technologies have significantly improved the precision, safety, and efficacy of neurovascular embolization procedures. Advanced delivery systems, including microcatheters and navigation tools, enable neurointerventionalists to reach intricate vascular structures. Furthermore, the integration of artificial intelligence (AI) and machine learning further refines procedural planning and execution, optimizing outcomes and reducing procedural times, which drive this market growth.

Threat:

Economic downturns

Economic downturns impact patients' ability to afford neurovascular embolization procedures and often face constraints and cost-cutting measures. This can lead to a reduction in funding for medical procedures, and individuals may face challenges in securing adequate health insurance coverage or may have limited resources. Additionally, economic downturns can disrupt the overall healthcare ecosystem, including physician practices and referral patterns. Physicians may experience reduced patient volumes or changes, which are hampering this market.

Covid-19 Impact

The COVID-19 pandemic has had several negative impacts on the neurovascular embolization market. The pandemic led to disruptions in healthcare services globally, procedures including certain neurovascular interventions like embolization, which were deferred or cancelled, impacting the overall procedural volume. Logistic challenges also impacted the availability of medical devices, including those used in neurovascular embolization. In addition, the shift in healthcare priorities and the financial strain on healthcare systems also hindered this market size.

The embolic coils segment is expected to be the largest during the forecast period

The embolic coil segment is estimated to hold the largest share due to its focus on the treatment of vascular abnormalities in the brain. This technique involves the deployment of platinum or other biocompatible coils through a catheter directly into the blood vessel. These coils induce clot formation, promoting the natural healing process and preventing the risk of rupture. In addition, it is versatile in treating cerebrovascular conditions, including aneurysms and arteriovenous malformations, coupled with ongoing research and development efforts that are boosting this segment's expansion.

The aneurysm coiling and embolization segment is expected to have the highest CAGR during the forecast period

The aneurysm coiling and embolization segment is anticipated to have highest CAGR during the forecast period. It is a crucial intervention for treating vascular abnormalities in the brain, wherein a catheter is navigated through blood vessels to the site of the aneurysm. Platinum coils or other embolic devices are then deployed into the aneurysm, promoting blood clot formation and preventing rupture. Furthermore, aneurysm coiling and embolization procedures offer reduced invasiveness, shorter recovery times, and a lower risk of complications, and rising awareness among both healthcare providers and patients contributes to the sustained growth of this market.

Region with largest share:

Asia Pacific commanded the largest market share during the extrapolated period, owing to increased demand and advancements in healthcare infrastructure. Increasing healthcare awareness, improved diagnostic capabilities, and expanding access to healthcare services have heightened the demand for neurovascular embolization procedures. Furthermore, collaborative efforts between healthcare institutions and industry players have resulted in the development and introduction of innovative embolic materials and devices, which are driving this region's growth.

Region with highest CAGR:

Europe is expected to witness highest CAGR over the projection period, owing to a growing awareness of advanced neurointerventional procedures, including embolization. Key players such as Medtronic plc, Penumbra, Inc., MicroVention, and Acandis GmbH continue to evolve technological advancements in healthcare systems, contributing to improved patient outcomes. Furthermore, increasing incidences of cerebrovascular diseases, such as aneurysms and arteriovenous, are propelling this region's expansion.

Key players in the market

Some of the key players in the Neurovascular Embolization Market include Cerenovus, Penumbra Inc, Medtronic, Phenox GmbH, Stryker, Balt SAS, Shape Memory Medical Inc, Integra LifeSciences, B. Braun Melsungen AG, MicroVention Inc, Peter Lazic GmbH and Spartan Micro.

Key Developments:

In August 2023, Medtronic announced the outcome of the U.S. Food & Drug Administration (FDA) Circulatory System Devices Panel (CSDP) meeting to review data presented in support of the Medtronic Symplicity Spyral™ Renal Denervation (RDN) System.

In February 2022, CERENOVUS, an emerging leader in neurovascular care and part of Johnson & Johnson Medical Devices Companies,* announced the launch of EMBOGUARD™, a next generation balloon guide catheter to be used in endovascular procedures, including those for patients with acute ischemic stroke.

In June 2021, Johnson & Johnson Medical Devices Companies* announced the first patient was enrolled in the CERENOVUS-sponsored MEMBRANE study evaluating TruFill® n-BCA Liquid Embolic System in the embolization of middle meningeal artery (MMA) for treatment of chronic subdural hematoma (cSDH) as adjunct to surgical evacuation or as a stand-alone treatment.

In January 2020, MicroVention, Inc., a U.S. based subsidiary of Terumo and a global neurovascular company announced the FDA Premarket Approval (PMA) for the FRED® (Flow Re-Direction Endoluminal Device) device for the treatment of brain aneurysms.

Products Covered:

• Flow Diversion Devices
• Aneurysm Clips
• Embolic Coils
• Liquid Embolic Agents/Systems
• Other Products

Procedures Covered:

• Arteriovenous Malformation (AVM) Embolization
• Aneurysm Coiling and Embolization
• Other Procedures

End Users Covered:

• Specialty Clinics
• Hospitals
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 End User Analysis
• 3.8 Emerging Markets
• 3.9 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Neurovascular Embolization Market, By Product

• 5.1 Introduction
• 5.2 Flow Diversion Devices
• 5.3 Aneurysm Clips
• 5.4 Embolic Coils
• 5.5 Liquid Embolic Agents/Systems
• 5.6 Other Products

6 Global Neurovascular Embolization Market, By Procedure

• 6.1 Introduction
• 6.2 Arteriovenous Malformation (AVM) Embolization
• 6.3 Aneurysm Coiling and Embolization
• 6.4 Other Procedures

7 Global Neurovascular Embolization Market, By End User

• 7.1 Introduction
• 7.2 Specialty Clinics
• 7.3 Hospitals
• 7.4 Other End Users

8 Global Neurovascular Embolization Market, By Geography

• 8.1 Introduction
• 8.2 North America
  • 8.2.1 US
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 Italy
  • 8.3.4 France
  • 8.3.5 Spain
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 Japan
  • 8.4.2 China
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 New Zealand
  • 8.4.6 South Korea
  • 8.4.7 Rest of Asia Pacific
• 8.5 South America
  • 8.5.1 Argentina
  • 8.5.2 Brazil
  • 8.5.3 Chile
  • 8.5.4 Rest of South America
• 8.6 Middle East & Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 UAE
  • 8.6.3 Qatar
  • 8.6.4 South Africa
  • 8.6.5 Rest of Middle East & Africa

9 Key Developments

• 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 9.2 Acquisitions & Mergers
• 9.3 New Product Launch
• 9.4 Expansions
• 9.5 Other Key Strategies

10 Company Profiling

• 10.1 Cerenovus
• 10.2 Penumbra Inc
• 10.3 Medtronic
• 10.4 Phenox GmbH
• 10.5 Stryker
• 10.6 Balt SAS
• 10.7 Shape Memory Medical Inc
• 10.8 Integra LifeSciences
• 10.9 B. Braun Melsungen AG
• 10.10 MicroVention Inc
• 10.11 Peter Lazic GmbH
• 10.12 Spartan Micro